Journal
EPIGENETICS
Volume 15, Issue 6-7, Pages 715-727Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/15592294.2020.1712876
Keywords
Prostate cancer; DNA methylation; liquid biopsies; epigenomics; cfDNA
Funding
- Prostate Cancer Foundation
- Irish Cancer Society [PCT13MCD, CRS17SIL, CCRC13GAL]
- Movember (GAP1 Urine Biomarker Award)
- Science Foundation Ireland [15/IA/3104, 18/SPP/3522]
- Science Foundation Ireland (SFI) [15/IA/3104] Funding Source: Science Foundation Ireland (SFI)
Ask authors/readers for more resources
Background: Liquid biopsies offer significant potential for informing on cancer progression and therapeutic resistance via minimally invasive serial monitoring of genetic alterations. Although the cancer epigenome is a central driving force in most neoplasia, the accuracy of monitoring the tumor methylome using liquid biopsies remains relatively unknown. Objectives: to investigate how well two types of liquid biopsy (urine and blood) capture the prostate cancer methylome, and may thus serve as a non-invasive surrogate for studying the tumor epigenome. Methods: A cohort of four metastatic treatment naive prostate cancer (PCa) patients was selected. Matched biopsy cores (tumor and histologically matched-normal), post-DRE, pre-biopsy urine, and peripheral blood plasma were available for each subject. DNA methylation was profiled utilizing the Infinium (R) MethylationEPIC BeadChip (Illumina) and analysed using the RnBeads software. Significantly (FDR adjusted P < 0.05) differentially methylated probes (DMPs) between tumor and MN were identified and examined in the liquids (done at a grouped and individual subject level). Results: DNA methylation analysis of urine and blood in men with metastatic PCa showed highly correlated patterns between the different liquid types (rho = 0.93, P < 0.0001), with large contributions from non-tumor sources. DNA methylation profiles of liquids were more similar between subjects, than intra-individual liquid-tumor correlations. Overall, both urine and plasma are viable surrogates for tumor tissue biopsies, capturing up to 39.40% and 64.14% of tumor-specific methylation alterations, respectively. Conclusion: We conclude that both urine and blood plasma are easily accessible and sensitive biofluids for the study of PCa epigenomic alterations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available